Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: It appears to me the appointment to the BOD of Mr. Schrock is

"I have however said that I could not find any protections, monitoring measures, or oversight provisions in the Operating Agreement or elsewhere where PTSC had access to TPL's other technology licensing endeavors with MMP licensees/infringers ... yet another shortsighted decision by the BOD. "

Just curious as to why you would choose to lay this all on the BOD lap. My experience is that the legal team advising on and writing up the agreement should have covered all of these bases. Care to explain your thinking further?

Share
New Message
Please login to post a reply